[quote style=”boxed”]Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint (TMJ) implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.[/quote] More in depth analysis coming soon. In the meantime, the press release is below…..Read More »Breaking: FDA Orders Review of TMJ Implants
Have lots of people in your family been sick lately? Im finally getting over the flu…. Still tired, but wanting to get back to life! Today we are introducing a new weekly post… A weekly wrap up. Every Friday, we will cover any TMJ related research or health related news that we feel you might be interested in, as well as sharing anything that has been going on over the week here at TMJ Hope…either here on the blog, on the forum, or on our Facebook page. If there is ever anything you think your fellow TMJ Hope readers would like to know, maybe an article you came across or some news you think we would all like to read, please submit it! First, here is what we were up to here on TMJ Hope this week: State of the TMJ Hope Union– please stop by and let us know how we can help you in 2011! And now, on to the health news: New Painkiller With No Side Effects or Addictive Qualities May Be Ready in a Year – According to researchers at Stony Brook University, a new painkiller that blocks the sodium ion channel involved in the transmission of pain, may be available within the next two years. Scientists at Stony Brook found that this drug could control pain without the same side effects and addictive qualities of opioid drugs. Preparations of the drug in oral and topical forms are being developed now in England & Canada, and a US company announced recently that they have entered Phase I clinical trials as well.Read More »TMJ Hope Weekly Wrap Up
Propoxyphene, the active ingredient in Darvon & Darvocet, has been removed from the US market after a new clinical trial linked the drug with high risk of developing serious heart rhythm abnormalities. The FDA has asked the maker of the drug, Xanodyne Pharmaceuticals to withdraw… Read More »Darvocet & Darvon Removed from the Market
Propoxyphene, the active ingredient in Darvon & Darvocet, has been removed from the US market after a new clinical trial linked the drug with high risk of developing serious heart rhythm abnormalities. The FDA has asked the maker of the drug, Xanodyne Pharmaceuticals to withdraw… Read More »Darvocet & Darvon Removed from the Market